Renflexis 100 MG vials

Ended Awarded

Contract number
SPE2DR26FKN0R
Awardee
Awarding agency
Obligated
$5,125

Award facts

Contract value 100% obligated
$5,124.68 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $5,124.68 delivery order to Amerisourcebergen Drug Corp on July 10, 2026, for Renflexis 100 mg vials, with final completion on July 13, 2026.

The order is priced firm fixed price with no set-aside. Place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution, holding a single-award indefinite delivery contract with DLA Troop Support Medical valued at $4.999 million through December 2036 under the Pharmaceutical Prime Vendor Global Program Generation V, supporting worldwide military healthcare supply.

Quick answers

Who was awarded contract SPE2DR26FKN0R?

SPE2DR26FKN0R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 10, 2026.

How much is contract SPE2DR26FKN0R worth?

The government has obligated $5,125 on SPE2DR26FKN0R.

Is contract SPE2DR26FKN0R an order under another contract?

Yes. SPE2DR26FKN0R is a delivery order under SPE2DR25D1106, an indefinite delivery contract.

Was contract SPE2DR26FKN0R competed?

The extent of competition for SPE2DR26FKN0R was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award